February 2017 Issue Table Of Contents
Source: Life Science Leader

From The Editor
Feature Article
The Enterprisers
Capitol Perspectives
Companies To Watch
CEO Corner
Inside The Industry
- Getting An Accurate Count Of Counterfeit Drugs
- What To Know About Post-Grant Review And The Biotech Industry
- Most U.S. Pharmas Ignore Cuba, Despite Relaxed Rules
- What Gets Funded, What Dies Before It Gets To Pharma R&D
- Brexit Presents Opportunity For U.S. Life Sciences Companies
- The Ethical Implications Of Right-To-Try Laws
- How To Navigate Pharma Collaboration And Licensing Agreements
Leadership Lessons
Industry Leader
- Considerations For The Use Of Wearables In Clinical Trials
- How Patients Will Revolutionize Next-Generation Clinical Research
Ask The Board
This website uses cookies to ensure you get the best experience on our website. Learn more